Getting started was simple
We also used MetaboAnalyst v5.0 (Xia Lab @ McGill University, Montreal, QC, Canada) [30] to identify the metabolites that contribute to group separation using Partial Least Squares-Discriminant Analysis (PLS-DA), heat map, and pathway analysis
But for patients starting this therapy, one of the most common questions is: How often should GLP-1 injections be administered for the best results
This reflects a cost-containment decision by Kaiser CA and Blue Shield of California applied an identical BMI-40 restriction at the same time
Overall tolerability of the treatment was good, with the most common side effect being nausea, particularly during treatment initiation or dose adjustments, while diarrhea was reported by 5% of patients, which was dose-dependent and easily managed